edoxaban
Daiichi Sankyo
['cardio']
the envisage-tavi af trial, a study led by dr. , yielded the first risk score that can predict mortality for #atrialfibrillation patients who have undergone a successful transcatheter aortic valve replacement: #cardiotwitter #esccongress 
An international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for @MountSinaiNYC.